| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 28, 2019 | Director | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | -- | -- | |
| May 31, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | $10.68 | 87,628 | |
| May 31, 2019 | Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,780 | $18.79 | 83,848 | |
| May 31, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | -- | -- | |
| May 23, 2019 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 858 | $19.15 | 16,650 | |
| Apr 24, 2019 | SVP and General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,319 | $20.64 | 35,235 | |
| Apr 04, 2019 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 4,232 | $22.95 | 121,476 | |
| Feb 12, 2019 | SVP and GM of Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 490 | $22.90 | 13,543 | |
| Feb 01, 2019 | SVP and GM of Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 14,033 | |
| Feb 01, 2019 | SVP and GM of Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.